Newer-generation of Edwards transcatheter aortic valve systems: SAPIEN 3, Centera, and SAPIEN 3 Ultra

References

• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–1607.
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–2198.
   PubMed Web of Science ®Google Scholar
• Kodali S, Thourani VH, White J, et al. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J. 2016;37:2252–2262.
   PubMed Web of Science ®Google Scholar
• Herrmann HC, Thourani VH, Kodali SK, et al. One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis. Circulation. 2016;134:130–140.
   PubMed Web of Science ®Google Scholar
• Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–2225.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–1620.
   PubMed Web of Science ®Google Scholar
• Wendler O, Schymik G, Treede H, et al. SOURCE 3 registry: design and 30-day results of the european postapproval registry of the latest generation of the SAPIEN 3 transcatheter heart valve. Circulation. 2017;135:1123–1132.
   PubMed Web of Science ®Google Scholar
• Wendler O, Schymik G, Treede H, et al. SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve. Eur Heart J. 2017;38:2717–2726.
   PubMed Web of Science ®Google Scholar
• Reichenspurner H, Schaefer A, Schafer U, et al. Self-expanding transcatheter aortic valve system for symptomatic high-risk patients with severe aortic stenosis. J Am Coll Cardiol. 2017;70:3127–3136.
   PubMed Web of Science ®Google Scholar
• Reichenspurner H. One-year outcomes of CENTERA-EU trial assessing a novel self-expanding transcatheter heart valve. Presented at: EuroPCR; 2018 May 22; Paris, France; 2018.
   Google Scholar
• Bagur R, Choudhury T, Mamas MA. Transcatheter aortic valve implantation with the repositionable and fully retrievable Lotus Valve SystemTM. J Thorac Dis. 2017;9:2798–2803.
   PubMed Web of Science ®Google Scholar
• Bagur R, Teefy PJ, Kiaii B, et al. First North American experience with the transfemoral ACURATE-neoTM self-expanding transcatheter aortic bioprosthesis. Catheter Cardiovasc Interv. 2017;90:130–138.
   PubMed Web of Science ®Google Scholar
• Kotronias RA, Teitelbaum M, Webb JG, et al. Early versus standard discharge after transcatheter aortic valve replacement: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2018;11:1759–1771.
   PubMed Web of Science ®Google Scholar
• Bagur R, Solo K, Alghofaili S, et al. Cerebral embolic protection devices during transcatheter aortic valve implantation: systematic review and meta-analysis. Stroke. 2017;48:1306–1315.
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311:1503–1514.
   PubMed Web of Science ®Google Scholar
• Rogers T, Steinvil A, Gai J, et al. Choice of balloon-expandable versus self-expanding transcatheter aortic valve impacts hemodynamics differently according to aortic annular size. Am J Cardiol. 2017;119:900–904.
   PubMed Web of Science ®Google Scholar
• Husser O, Kim WK, Pellegrini C, et al. Multicenter comparison of novel self-expanding versus balloon-expandable transcatheter heart valves. JACC Cardiovasc Interv. 2017;10:2078–2087.
   PubMed Web of Science ®Google Scholar
• Kim WK, Blumenstein J, Liebetrau C, et al. Comparison of outcomes using balloon-expandable versus self-expanding transcatheter prostheses according to the extent of aortic valve calcification. Clin Res Cardiol. 2017;106:995–1004.
   PubMed Web of Science ®Google Scholar
• Mauri V, Kim WK, Abumayyaleh M, et al. Short-term outcome and hemodynamic performance of next-generation self-expanding versus balloon-expandable transcatheter aortic valves in patients with small aortic annulus: a multicenter propensity-matched comparison. Circ Cardiovasc Interv. 2017;10.
   PubMed Web of Science ®Google Scholar
• Tang GHL, Zaid S, George I, et al. Impact of aortic root anatomy and geometry on paravalvular leak in transcatheter aortic valve replacement with extremely large annuli using the Edwards SAPIEN 3 valve. JACC Cardiovasc Interv. 2018;11:1377–1387.
   PubMed Web of Science ®Google Scholar
• Eitan A, Witt J, Stripling J, et al. Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli >/=26 mm. Catheter Cardiovasc Interv. 2018 Mar 9. DOI:10.1002/ccd.27588[ Epub ahead of print.]
   PubMed Web of Science ®Google Scholar
• van Rosendael PJ, Delgado V, Bax JJ. Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review. Eur Heart J. 2018;39:2003–2013.
   PubMed Web of Science ®Google Scholar
• Durko AP, Osnabrugge RL, Van Mieghem NM, et al. Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections. Eur Heart J. 2018;39:2635–2642.
   PubMed Web of Science ®Google Scholar
• Bagur R, Rodes-Cabau J, Gurvitch R, et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv. 2012;5:540–551.
   PubMed Web of Science ®Google Scholar
• Manoharan G, Walton AS, Brecker SJ, et al. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv. 2015;8:1359–1367.
   PubMed Web of Science ®Google Scholar
• Popma JJ, Reardon MJ, Khabbaz K, et al. Early clinical outcomes after transcatheter aortic valve replacement using a novel self-expanding bioprosthesis in patients with severe aortic stenosis who are suboptimal for surgery: results of the evolut R U.S. study. JACC Cardiovasc Interv. 2017;10:268–275.
   PubMed Web of Science ®Google Scholar
• Kalra SS, Firoozi S, Yeh J, et al. Initial experience of a second-generation self-expanding transcatheter aortic valve: the UK & Ireland evolut R implanters’ registry. JACC Cardiovasc Interv. 2017;10:276–282.
   PubMed Web of Science ®Google Scholar
• Forrest JK, Mangi AA, Popma JJ, et al. Early outcomes with the evolut PRO repositionable self-expanding transcatheter aortic valve with pericardial wrap. JACC Cardiovasc Interv. 2018;11:160–168.
   PubMed Web of Science ®Google Scholar
• Mollmann H, Hengstenberg C, Hilker M, et al. Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry. EuroIntervention. 2018;13:e1764–e1770.
   PubMed Web of Science ®Google Scholar
• Conradi L, Hilker M, Kempfert J, et al. Prospective multicentre evaluation of a novel, low-profile transapical delivery system for self-expandable transcatheter aortic valve implantation: 6-month outcomes. Eur J Cardiothorac Surg. 2018;54:762–767.
   PubMedGoogle Scholar
• Mollmann H Transcatheter aortic valve implantation for severe aortic valve stenosis with the ACURATE neo 2 valve system: 30-day safety and performance outcomes. Presented at PCR London Valves; 2018 Sept; London, England; 2018.
   Google Scholar
• Meredith IT, Dumonteil N, Blackman DJ, et al. Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients. EuroIntervention. 2017;13:788–795.
   PubMed Web of Science ®Google Scholar
• Falk V, Wohrle J, Hildick-Smith D, et al. Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study. Eur Heart J. 2017;38:3359–3366.
   PubMed Web of Science ®Google Scholar
• Feldman TE, Reardon MJ, Rajagopal V, et al. Effect of mechanically expanded vs self-expanding transcatheter aortic valve replacement on mortality and major adverse clinical events in high-risk patients with aortic stenosis: the REPRISE III randomized clinical trial. JAMA. 2018;319:27–37.
   PubMed Web of Science ®Google Scholar
• Van Mieghem N Transcatheter aortic valve replacement using the Lotus valve with depth guard: first report from the RESPOND extension study. Presented at CRT; 2017 Feb 20; Washington DC, USA; 2017.
   Google Scholar
• Foroutan F, Guyatt GH, Otto CM, et al. Structural valve deterioration after transcatheter aortic valve implantation. Heart. 2017;103:1899–1905.
   PubMed Web of Science ®Google Scholar